Skip to main content
OpenTrials

Clinical trial condition

Unresectable Locally Advanced Pancreatic Carcinoma

Explore clinical trials studying Unresectable Locally Advanced Pancreatic Carcinoma. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Locally Advanced Pancreatic Carcinoma trial results

Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.

NCT03076216

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Cedars Sinai Department of Radiation Oncology Los Angeles, California, United States
  • Moffitt Cancer Centre Tampa, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane

NCT03003078

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Corrimal Cancer Care Clinic, 20-22 Underwood St Corrimal, New South Wales, Australia
  • Department of Medical Oncology, Royal North Shore Hospital St Leonards, New South Wales, Australia
  • The Kinghorn Cancer Centre, St Vincent's Hospital Sydney, New South Wales, Australia
  • The Crown Princess Mary Cancer Centre, Westmead Hospital Westmead, New South Wales, Australia
View Trial Details

Related conditions